Skip to main content
logo
Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,735.00
+365.00 (8.35%)
At close: Jul 31, 2026

Pharos iBio Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----30057
Revenue Growth
----426.32%-69.63%
Gross Profit
-19.42-20.32-25.93-11.02107.524.91
Operating Income
-10,726-11,507-12,601-10,117-10,619-8,406
Net Income
-9,937-10,757-10,560-8,858-17,062-31,471
Earnings Per Share
-767.76-830.89-817.00-732.03-1921.10-5422.59
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
23,80926,01415,66825,48715,07923,812
Total Debt
8,4727,945123.72304.95365.68591.61
Net Cash (Debt)
15,33718,06915,54425,18214,71423,221
Net Cash Growth
20.18%16.24%-38.27%71.15%-36.64%63.31%
Net Cash Per Share
1184.971395.731202.592080.941656.704001.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7,953-8,347-9,327-7,413-8,184-7,319
Capital Expenditures
-26.4-15.22-676.78-839.64-328.28-1,170
Free Cash Flow
-7,980-8,362-10,004-8,253-8,512-8,489
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----35.84%8.61%
Operating Margin
-----3539.83%-14747.27%
Pretax Margin
-----5687.23%-55211.96%
Profit Margin
-----5687.23%-55211.96%
FCF Margin
-----2837.42%-14892.94%

Valuation
Selected indicators aren't available for this stock.